Sigma Planning Corp’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Hold |
0
| – | – | – | 1486 |
|
|
2021
Q4 | – | Sell |
-14,440
| Closed | -$110K | – | 1474 |
|
|
2021
Q3 | $110K | Buy |
14,440
+1,110
| +8% | +$8.46K | ﹤0.01% | 1295 |
|
|
2021
Q2 | $129K | Sell |
13,330
-2,050
| -13% | -$19.8K | ﹤0.01% | 1323 |
|
|
2021
Q1 | $127K | Buy |
15,380
+3,930
| +34% | +$32.5K | ﹤0.01% | 1246 |
|
|
2020
Q4 | $78K | Sell |
11,450
-8,160
| -42% | -$55.6K | ﹤0.01% | 1142 |
|
|
2020
Q3 | $219K | Buy |
+19,610
| New | +$219K | 0.01% | 910 |
|
|
2019
Q3 | – | Sell |
-41,500
| Closed | -$111K | – | 1065 |
|
|
2019
Q2 | $111K | Buy |
41,500
+1,000
| +2% | +$2.68K | 0.01% | 940 |
|
|
2019
Q1 | $192K | Buy |
40,500
+20,250
| +100% | +$96K | 0.01% | 849 |
|
|
2018
Q4 | $49K | Buy |
20,250
+1,000
| +5% | +$2.42K | ﹤0.01% | 819 |
|
|
2018
Q3 | $85K | Hold |
19,250
| – | – | 0.01% | 905 |
|
|
2018
Q2 | $139K | Buy |
19,250
+4,750
| +33% | +$34.3K | 0.01% | 852 |
|
|
2018
Q1 | $75K | Buy |
+14,500
| New | +$75K | 0.01% | 831 |
|